Abstract
Objective: To evaluate the effectiveness of the Modified Atkins Diet in reducing seizure frequency and to analyze its adverse effects, adherence, and duration of intervention in children with refractory epilepsy. Methods: An integrative review was conducted using the databases Medical Literature Analysis and Retrieval System Online (MEDLINE), PubMed, Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), and Periódicos CAPES, including studies published between 2020 and 2026, based on the descriptors “modified atkins diet,” “children,” and “epilepsy.” Full-text articles addressing the application of the diet in the pediatric population with drug-resistant epilepsy were considered eligible. Results: Ten studies comprised the final sample. A ≥50% reduction in seizure frequency was observed, with cases achieving ≥90% reduction and complete remission, in addition to an early onset of therapeutic effect. Adverse effects were predominantly mild and gastrointestinal, especially constipation. The greater flexibility of the protocol favored adherence, although dropouts were reported. Final considerations: The Modified Atkins Diet appears to be an effective and safe therapeutic alternative; however, more robust clinical trials are needed to strengthen the current evidence.
References
ARCHNA GARG D, et al. Modified Atkins diet versus levetiracetam for non-surgical drug-resistant epilepsy in children: an open-label randomized study. Seizure, 2022; 103: 61-67.
ASSOCIAÇÃO BRASILEIRA DE EPILEPSIA (ABE). Epilepsia refratária. ABE, 2026.
BRASIL. Ministério da Saúde. Epilepsia: conheça a doença e os tratamentos disponíveis no SUS. Brasília-DF, 2022. Disponível em: https://www.gov.br/saude.
CABRERA AM, et al. Tratamiento de la epilepsia refractaria: comparación entre la dieta cetogénica clásica y la dieta Atkins modificada en términos de eficacia, adherencia y efectos adversos. Nutrición Hospitalaria, 2024; 38(6): 1144-1148.
DANIŁOWSKA K, et al. New pharmacological therapies in the treatment of epilepsy in the pediatric population. Journal of Clinical Medicine, 2024; 13: 3567.
EL-SHAFIE AM, et al. Impact of two types of ketogenic diet on refractory childhood epilepsy. Pediatric Research, 2023; 94(6): 1978-1989.
GUERY D, RHEIMS S. Clinical management of drug-resistant epilepsy: a review of current strategies. Neuropsychiatric Disease and Treatment, 2021; 17: 2229-2242.
GUPTA S, et al. Modified Atkins diet versus low glycemic index treatment for drug-resistant epilepsy in children: an open-label randomized controlled trial. Indian Pediatrics, 2021; 58: 815-819.
KOSSOFF EH. The Modified Atkins Diet for epilepsy: two decades of an “alternative” ketogenic dietary therapy. Pediatric Neurology, 2023; 147: 82-87.
MALINOWSKA D, ŻENDZIAN-PIOTROWSKA M. Ketogenic diet: a review of dietary compositions, mechanisms of action, and clinical applications. Journal of Nutrition and Metabolism, 2024: 6666171.
MULYAN A, et al. Sequential treatment with Modified Atkins Diet and Low Glycemic Index Treatment for drug-resistant epilepsy in children. Neuropediatrics, 2024; 55(5): 289-293.
MUTARELLI A, et al. Dieta Atkins modificada para epilepsia resistente a medicamentos: uma revisão sistemática e meta-análise de ensaios clínicos randomizados Convulsão - European Journal of Epilepsy, 2023; 112: 77-83.
NASIRI J, et al. Causes and risk factors of drug-resistant epilepsy in children. Iranian Journal of Child Neurology, 2023; 17(3): 89-97.
PARK EG, et al. Uso da dieta Atkins modificada em epilepsia pediátrica intratável. J Epilepsy Res., 2018; 8(1): 20-26.
PATEL P, MOSHÉ SL. The evolution of concepts of seizures and epilepsy: what’s in a name? Epilepsia Open, 2020; 5(1): 22-35.
REBOLLO GMJ, et al. Dieta cetogénica en pacientes con epilepsia refractaria. Revista Chilena de Pediatría, 2020; 91(5): 697-704.
SONDHI V, et al. Efficacy of ketogenic diet, Modified Atkins Diet, and low glycemic index treatment in children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatrics, 2020; 174(10): 944-951.
SUMADEWI KT, et al. Mecanismos biomoleculares de convulsões epilépticas e epilepsia: uma revisão. Acta Epileptologica, 2023; 5: 28.
TSANG E, et al. Nutritional adequacy of the ketogenic diet in pediatric epilepsy: detailed nutrient analysis and dietary recommendations. Clinical Nutrition ESPEN, 2025; 69: 274-285.
YILDIRIM GK, et al. Evaluation of ketogenic dietary therapy in children diagnosed with drug-resistant epilepsy: a single-center experience. Turkish Journal of Pediatrics, 2022; 64(3): 435-445.
